Qkine, a manufacturer of animal-free, highly bioactive, and innovative proteins, have extended its global reach through a sales distribution agreement with Biogenuix, an Indian distribution partner.
”We are delighted to be working with the team at Biogenuix to enhance the availability of our products to customers in India. Identifying the correct distribution partner in India was an important element of our commercial strategy, and we have been fortunate to appoint Biogenuix who have shared customer service values and scientific synergies.” commented Dr Catherine Elton, CEO and co-founder of Qkine.
Qkine, based in Cambridge, UK, is an innovative manufacturer of complex bioactive proteins for stem cell and organoid culture. Stem cell research in India has progressed at a phenomenal pace and partnering with Biogeniux will allow Qkine to better service customers in India. Biogeniux will have access to the whole Qkine portfolio which includes growth factors and cytokines for stem cell applications such as organoid, neural, hematopoetic, and iPSC maintenance and differentiation.
Biogenuix, based in New Delhi, India, has extensive knowledge and presence within the Indian life science, clinical diagnostics, and regenerative medicine markets. Biogenuix and Qkine share a focus on product quality and the emerging areas of personalized medicine and drug discovery.
Mr. Anil Shrivastava, Director at Biogenuix, commented: “This is a very excited period for Stem Cell & Regenerative Medicine market in India, Indian Stem Cell & Regenerative market estimated around USD 0.47 billion in 2019 & is expected to grow around 13% CAGR from Fy-21 to FY26. Major growth drivers are continuous advancement in tissue engineering, 3d cell culture, organoids culture and growing awareness about stem cell/regenerative medicine for addressing chronic cases of genetic disorders. At present in India approved clinically indications for stem cell therapy are, Bone Marrow Transplant (BMT) & Haemopoietic Stem Cell Transplant (HSCT) to treat blood cancers and different blood disorders. For other diseases, such as Thalassemia, damaged cornea, and burns etc. studies are being conducted to find if stem cells can be helpful in curing these diseases. Future look bright because Stem cells/3d cell culture/organoids can grow new organs or tissues in the lab, reducing dependency on organ donations and the risk of organ rejection in coming years.”
Biogenuix and Qkine are committed to providing the highest quality support for customers across the Indian region.